ADVANCED HODGKIN LYMPHOMA
Clinical trials for ADVANCED HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ADVANCED HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart chemo: PET scans guide tailored treatment for hodgkin lymphoma
Disease control Recruiting nowThis study tests a new treatment for advanced Hodgkin lymphoma that combines the immunotherapy drug nivolumab with chemotherapy. Doctors use PET scans during treatment to see how well it's working and adjust therapy accordingly. The goal is to improve outcomes while reducing side…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Blood test may let some hodgkin patients skip extra chemo
Disease control Recruiting nowThis study tests whether a blood test that measures tumor DNA can help doctors safely reduce the amount of chemotherapy for people with advanced Hodgkin lymphoma. About 125 participants will receive either fewer or standard chemo cycles based on their test results. The goal is to…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope: shorter chemo combo for hodgkin lymphoma shows promise
Disease control Recruiting nowThis study tests a shorter course of a drug combination called BrECADD for people with advanced Hodgkin lymphoma (stage 2B to IV). About 48 adults aged 18 to 60 will receive this treatment to see if it works well and is tolerable. Researchers will also check if a blood test for t…
Matched conditions: ADVANCED HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 08, 2026 12:03 UTC